These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32576176)

  • 21. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.
    Siefker-Radtke AO; Gee J; Shen Y; Wen S; Daliani D; Millikan RE; Pisters LL
    J Urol; 2003 Apr; 169(4):1295-8. PubMed ID: 12629346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel approach of laparoscopic transperitoneal en bloc resection of urachal tumor and umbilectomy with a comparison of various techniques.
    Chan ES; Ng CF; Chui KL; Lo KL; Hou SM; Yip SK
    J Laparoendosc Adv Surg Tech A; 2009 Jun; 19(3):423-6. PubMed ID: 19405800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform.
    Xing F; Liu YC; Huang S; Lyu X; Su SM; Chan UI; Wu PC; Yan Y; Ai N; Li J; Zhao M; Rajendran BK; Liu J; Shao F; Sun H; Choi TK; Zhu W; Luo G; Liu S; Xu L; Chan KL; Zhao Q; Miao K; Luo KQ; Ge W; Xu X; Wang G; Liu TM; Deng CX
    Theranostics; 2021; 11(19):9415-9430. PubMed ID: 34646378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells.
    Lin JF; Lin YC; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
    Drug Des Devel Ther; 2016; 10():1501-13. PubMed ID: 27143856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survival.
    Kawakami S; Kageyama Y; Yonese J; Fukui I; Kitahara S; Arai G; Hyouchi N; Suzuki M; Masuda H; Hayashi T; Okuno T; Kihara K
    Urology; 2001 Sep; 58(3):462. PubMed ID: 11549502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robotic assisted laparoscopic partial cystectomy and urachal resection for urachal adenocarcinoma.
    Spiess PE; Correa JJ
    Int Braz J Urol; 2009; 35(5):609. PubMed ID: 19860941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The comparison between dual inhibition of mTOR with MAPK and PI3K signaling pathways in KRAS mutant NSCLC cell lines.
    Dogan Turacli I; Ozkan AC; Ekmekci A
    Tumour Biol; 2015 Dec; 36(12):9339-45. PubMed ID: 26108998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urachal carcinoma: A case of a rare neoplasm.
    Moreira I; Coelho S; Rodrigues Â; Patrão AS; Maurício MJ
    Curr Probl Cancer; 2021 Dec; 45(6):100711. PubMed ID: 33541722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
    Wei L; Chintala S; Ciamporcero E; Ramakrishnan S; Elbanna M; Wang J; Hu Q; Glenn ST; Murakami M; Liu L; Gomez EC; Sun Y; Conroy J; Miles KM; Malathi K; Ramaiah S; Anbarasu A; Woloszynska-Read A; Johnson CS; Conroy J; Liu S; Morrison CD; Pili R
    Oncotarget; 2016 Nov; 7(47):76374-76389. PubMed ID: 27823983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer.
    Venkatesha VA; Joshi A; Venkataraman M; Sonawane V; Bhatia D; Tannu P; Bose J; Choudhari S; Srivastava A; Pandey PK; Lad VJ; Sangana R; Ahmed T; Damre A; Deore V; Sahu B; Kumar S; Sharma S; Agarwal VR
    Mol Cancer; 2014 Dec; 13():259. PubMed ID: 25466244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Colloid carcinoma of the urachus. Cytologic diagnosis and differential diagnostic classification].
    Eidt S; Hake R; Witt J
    Pathologe; 1995 Mar; 16(2):139-42. PubMed ID: 7761359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case Report: Bladder adenocarcinoma: primary or urachal?
    Tejeda-Mariaca JE; Ordoñez-Alcantara M; Bello-Sedano A; Perez-Cornejo V; Grandez-Urbina JA
    F1000Res; 2019; 8():1717. PubMed ID: 32832071
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic urachal carcinoma of the ovary.
    Jo EJ; Choi CH; Bae DS; Park SH; Hong SR; Lee JH
    J Obstet Gynaecol Res; 2011 Dec; 37(12):1833-7. PubMed ID: 21794003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia.
    George AA; Paz H; Fei F; Kirzner J; Kim YM; Heisterkamp N; Abdel-Azim H
    PLoS One; 2015; 10(9):e0137917. PubMed ID: 26360058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urachal adenocarcinoma: A case report and review of the literature.
    Gural Z; Yücel S; Oskeroğlu S; Ağaoğlu F
    J Cancer Res Ther; 2022; 18(1):291-293. PubMed ID: 35381804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined endoscopic and laparoscopic en bloc resection of the urachus and the bladder dome in a rare case of urachal carcinoma.
    Porpiglia F; Cracco CM; Terrone C; Cossu M; Renard J; Billia M; Scarpa RM
    Int J Urol; 2007 Apr; 14(4):362-4. PubMed ID: 17470173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles.
    Tidwell TR; Røsland G; Tronstad KJ; Søreide K; Hagland HR
    Cancer Med; 2024 Jun; 13(11):e7318. PubMed ID: 38872378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer.
    Wang H; Lv Q; Xu Y; Cai Z; Zheng J; Cheng X; Dai Y; Jänne PA; Ambrogio C; Köhler J
    EBioMedicine; 2019 Nov; 49():106-117. PubMed ID: 31668570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.